TRIM47 and intrahepatic cholangiocarcinoma: In addition, although this study identified TRIM47 as a therapeutic target for ICC, at the clinical level, methods to inhibit TRIM47, such as targeted drugs, require further in-depth exploration and experimental validation, particularly concerning toxicity in normal cells.